Cargando…

Safety of simultaneous vaccination with COVID-19 vaccines in the Vaccine Safety Datalink

INTRODUCTION: Safety data on simultaneous vaccination (SV) with primary series monovalent COVID-19 vaccines and other vaccines are limited. We describe SV with primary series COVID-19 vaccines and assess 23 pre-specified health outcomes following SV among persons aged ≥5 years in the Vaccine Safety...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kenigsberg, Tat'Yana A., Hanson, Kayla E., Klein, Nicola P., Zerbo, Ousseny, Goddard, Kristin, Xu, Stanley, Yih, W. Katherine, Irving, Stephanie A., Hurley, Laura P., Glanz, Jason M., Kaiser, Robyn, Jackson, Lisa A., Weintraub, Eric S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Science 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10267508/ https://www.ncbi.nlm.nih.gov/pubmed/37344264 http://dx.doi.org/10.1016/j.vaccine.2023.06.042

Ejemplares similares

Dashboard development for near real-time visualization of COVID-19 vaccine safety surveillance data in the Vaccine Safety Datalink
por: Kenigsberg, Tat'Yana A., et al.
Publicado: (2022)

Vaccine Safety Datalink infrastructure enhancements for evaluating the safety of maternal vaccination
por: Naleway, Allison L., et al.
Publicado: (2021)

Incidence of Guillain-Barré Syndrome After COVID-19 Vaccination in the Vaccine Safety Datalink
por: Hanson, Kayla E., et al.
Publicado: (2022)

1163. Influenza Vaccination Coverage through December among Persons Ages Six Months and Older in the Vaccine Safety Datalink, 2017-18 through 2022-23 Influenza Seasons
por: Irving, Stephanie, et al.
Publicado: (2023)

Safety of measles, mumps, and rubella vaccine in adolescents and adults in the vaccine safety Datalink
por: Hanson, Kayla E., et al.
Publicado: (2023)

Inactivated influenza vaccine and spontaneous abortion in the Vaccine Safety Datalink in 2012–13, 2013–14, and 2014–15
por: Donahue, James G., et al.
Publicado: (2019)

1162. Influenza Vaccination Among Pregnant People in the Vaccine Safety Datalink, 2016-17 through 2022-23 Influenza Seasons
por: Irving, Stephanie, et al.
Publicado: (2023)

2763. Uptake and Safety of Measles-Mumps-Rubella (MMR) Vaccine in Adolescents and Adults in the Vaccine Safety Datalink
por: Hanson, Kayla E, et al.
Publicado: (2019)

A broad assessment of covid-19 vaccine safety using tree-based data-mining in the vaccine safety datalink
por: Yih, W. Katherine, et al.
Publicado: (2023)

Monitoring vaccine safety using the vaccine safety Datalink: Assessing capacity to integrate data from Immunization Information systems
por: Groom, Holly C., et al.
Publicado: (2022)

A decade of data: Adolescent vaccination in the vaccine safety datalink, 2007 through 2016
por: Irving, Stephanie A., et al.
Publicado: (2022)

Tree-based data mining for safety assessment of first COVID-19 booster doses in the Vaccine Safety Datalink
por: Katherine Yih, W., et al.
Publicado: (2023)

COVID-19 Vaccination Coverage Among Insured Persons Aged ≥16 Years, by Race/Ethnicity and Other Selected Characteristics — Eight Integrated Health Care Organizations, United States, December 14, 2020–May 15, 2021
por: Pingali, Cassandra, et al.
Publicado: (2021)

Patterns of pneumococcal vaccination and revaccination in elderly and non-elderly adults: a Vaccine Safety Datalink study
por: Jackson, Lisa A, et al.
Publicado: (2009)

177. Safety of Measles and Pertussis-containing Vaccines in School-age Children Previously Diagnosed with Autism Spectrum Disorders
por: Zerbo, Ousseny, et al.
Publicado: (2020)

Premature Puberty and Thimerosal-Containing Hepatitis B Vaccination: A Case-Control Study in the Vaccine Safety Datalink
por: Geier, David A., et al.
Publicado: (2018)

Guillain-Barré Syndrome, Influenza Vaccination, and Antecedent Respiratory and Gastrointestinal Infections: A Case-Centered Analysis in the Vaccine Safety Datalink, 2009–2011
por: Greene, Sharon K., et al.
Publicado: (2013)

Vaccine Safety Surveillance Systems: Critical Elements and Lessons Learned in the Development of the US Vaccine Safety Datalink’s Rapid Cycle Analysis Capabilities
por: Davis, Robert L.
Publicado: (2013)

Risk of myocarditis and pericarditis following BNT162b2 and mRNA-1273 COVID-19 vaccination
por: Goddard, Kristin, et al.
Publicado: (2022)

2297. COVID-19 Vaccine Effectiveness Among Pregnant People
por: Zerbo, Ousseny, et al.
Publicado: (2022)

Changes in incidence rates of outcomes of interest in vaccine safety studies during the COVID-19 pandemic
por: Xu, Stanley, et al.
Publicado: (2022)

Vaccine effectiveness of cell-culture relative to egg-based inactivated influenza vaccine during the 2017-18 influenza season
por: Klein, Nicola P., et al.
Publicado: (2020)

LB15. Vaccine Effectiveness of Flucelvax Relative to Inactivated Influenza Vaccine During the 2017–18 Influenza Season in Northern California
por: Klein, Nicola P, et al.
Publicado: (2018)

COVID-19 Vaccination Coverage Among Pregnant Women During Pregnancy — Eight Integrated Health Care Organizations, United States, December 14, 2020–May 8, 2021
por: Razzaghi, Hilda, et al.
Publicado: (2021)

Frequency of medically attended adverse events following tetanus and diphtheria toxoid vaccine in adolescents and young adults: a Vaccine Safety Datalink study
por: Jackson, Lisa A, et al.
Publicado: (2009)

Thimerosal-containing Hepatitis B Vaccine Exposure is Highly Associated with Childhood Obesity: A Case-control Study Using the Vaccine Safety Datalink
por: Geier, David A., et al.
Publicado: (2016)

The Pioneering Role of the Vaccine Safety Datalink Project (VSD) to Advance Collaborative Research and Distributed Data Networks
por: Fahey, Kevin R.
Publicado: (2015)

Thimerosal-Containing Hepatitis B Vaccination and the Risk for Diagnosed Specific Delays in Development in the United States: A Case-Control Study in the Vaccine Safety Datalink
por: Geier, David A., et al.
Publicado: (2014)

Effectiveness of COVID-19 vaccination during pregnancy by circulating viral variant
por: Zerbo, Ousseny, et al.
Publicado: (2023)

Parental risk factors for fever in their children 7–10 days after the first dose of measles-containing vaccines
por: Zerbo, Ousseny, et al.
Publicado: (2019)

Extended surveillance to assess safety of 9-valent human papillomavirus vaccine
por: Sundaram, Maria E., et al.
Publicado: (2022)

2275. Parental Risk Factors for Fever in their Children 7–10 Days After the First Dose of Measles-Containing Vaccines
por: Zerbo, Ousseny, et al.
Publicado: (2018)

Genetic associations with a fever after measles-containing vaccines
por: Klein, Nicola P., et al.
Publicado: (2020)

504. Individual and Neighborhood Factors Associated with Failure to Vaccinate Against COVID-19 Among Pregnant Persons
por: Zerbo, Ousseny, et al.
Publicado: (2023)

Identification and description of mumps cases in a non-outbreak setting and evaluation of the effectiveness of mumps-containing vaccines over time
por: Zerbo, Ousseny, et al.
Publicado: (2020)

2766. Identification and Description of Mumps Cases in a Non-Outbreak Setting and Evaluation of the Effectiveness of Mumps Containing Vaccines Over Time
por: Zerbo, Ousseny, et al.
Publicado: (2019)

Vaccine safety
por: Offit, Paul A., et al.
Publicado: (2013)

Vaccine Safety
por: Destefano, Frank, et al.
Publicado: (2018)

Timeliness of recording in the Clinical Practice Research Datalink (CPRD) - an initial step in the implementation of near real-time vaccine safety surveillance
por: Leite, Andreia, et al.
Publicado: (2017)

Vaccine safety
por: Offit, Paul A., et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_genguku05kj1ta0ubvfp5br720